The Consequence of Immune Suppressive Cells in the Use of Therapeutic Cancer Vaccines and Their Importance in Immune Monitoring

Por Vergati, Matteo, Schlom, Jeffrey, Tsang, Kwong Y.
Publicado em 2011

Strategies for Cancer Vaccine Development

Por Vergati, Matteo, Intrivici, Chiara, Huen, Ngar-Yee, Schlom, Jeffrey, Tsang, Kwong Y.
Publicado em 2010

Estimated Glomerular Filtration Rate Is an Easy Predictor of Venous Thromboembolism in Cancer Patients Undergoing Platinum-Based Chemotherapy

Por Ferroni, Patrizia, Guadagni, Fiorella, Laudisi, Anastasia, Vergati, Matteo, Riondino, Silvia, Russo, Antonio, Davì, Giovanni, Roselli, Mario
Publicado em 2014

Identification and characterization of agonist epitopes of the MUC1-C oncoprotein

Por Jochems, Caroline, Tucker, Jo A, Vergati, Matteo, Boyerinas, Benjamin, Gulley, James L, Schlom, Jeffrey, Tsang, Kwong-Yok
Publicado em 2013

Identification and characterization of agonist epitopes of the MUC1-C oncoprotein

Por Jochems, Caroline, Tucker, Jo A., Vergati, Matteo, Boyerinas, Benjamin, Gulley, James L., Schlom, Jeffrey, Tsang, Kwong-Yok
Publicado no Cancer Immunol Immunother (2013)

Maturation of human dendritic cells with Saccharomyces cerevisiae (yeast) reduces the number and function of regulatory T cells and enhances the ratio of antigen-specific effectors...

Por Cereda, Vittore, Vergati, Matteo, Huen, Ngar-Yee, di Bari, Maria Giovanna, Jochems, Caroline, Intrivici, Chiara, Gulley, James L., Apelian, David, Schlom, Jeffrey, Tsang, Kwong Y.
Publicado em 2011

Effect of Talactoferrin Alfa on the Immune System in Adults With Non-Small Cell Lung Cancer

Por Madan, Ravi A., Tsang, Kwong-Yok, Bilusic, Marijo, Vergati, Matteo, Poole, Diane J., Jochems, Caroline, Tucker, Jo A., Schlom, Jeffrey, Giaccone, Giuseppe, Gulley, James L.
Publicado em 2013

Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination

Por Vergati, Matteo, Cereda, Vittore, Madan, Ravi A., Gulley, James L., Huen, Ngar-Yee, Rogers, Connie J., Hance, Kenneth W., Arlen, Philip M., Schlom, Jeffrey, Tsangsa, Kwong Y.
Publicado em 2010

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Por Madan, Ravi A, Mohebtash, Mahsa, Arlen, Philip M, Vergati, Matteo, Rauckhorst, Myrna, Steinberg, Seth M, YTsang, Kwong, Poole, Diane J, Parnes, Howard L, Wright, John J, Dahut, William L, Schlom, Jeffrey, Gulley, James L
Publicado no Lancet Oncol (2012)

Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer

Por Huen, Ngar-Yee, Pang, Alan Lap-Yin, Tucker, Jo A., Lee, Tin-Lap, Vergati, Matteo, Jochems, Caroline, Intrivici, Chiara, Cereda, Vittore, Chan, Wai-Yee, Rennert, Owen M., Madan, Ravi A., Gulley, James L., Schlom, Jeffrey, Tsang, Kwong Y.
Publicado em 2013

Immunologic and Prognostic Factors Associated with Overall Survival Employing a Poxviral-based PSA Vaccine in Metastatic Castrate-resistant Prostate Cancer

Por Gulley, James L., Arlen, Philip M., Madan, Ravi A., Tsang, Kwong-Yok, Pazdur, Mary P., Skarupa, Lisa, Jones, Jacquin L., Poole, Diane J., Higgins, Jack P., Hodge, James W., Cereda, Vittore, Vergati, Matteo, Steinberg, Seth M., Halabi, Susan, Jones, Elizabeth, Chen, Clara, Parnes, Howard, Wright, John J., Dahut, William L., Schlom, Jeffrey
Publicado em 2009